Published in Int J Antimicrob Agents on September 01, 1999
Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity. Antimicrob Agents Chemother (2015) 0.79
Toxoplasma gondii and schizophrenia: a review of published RCTs. Parasitol Res (2017) 0.75
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol (1997) 5.91
Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol (2000) 4.59
Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother (1989) 2.30
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (1999) 1.96
Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke (1996) 1.84
In-vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother (1986) 1.71
Activity of ten antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother (1978) 1.66
Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun (1989) 1.65
Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.62
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob Agents Chemother (1987) 1.62
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. Antimicrob Agents Chemother (1988) 1.61
Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology (1990) 1.61
A plasmid-mediated cephalosporinase from Achromobacter species. J Infect Dis (1982) 1.55
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae. Antimicrob Agents Chemother (1987) 1.55
Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg (1994) 1.51
Needle muscle biopsy in the investigation of neuromuscular disorders. Muscle Nerve (1998) 1.45
Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb Pathog (1990) 1.42
Effect of motility and chemotaxis on the invasion of Salmonella typhimurium into HeLa cells. Microb Pathog (1990) 1.38
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother (2003) 1.33
Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res (1996) 1.33
Identification of Campylobacter jejuni surface proteins that bind to Eucaryotic cells in vitro. Infect Immun (1990) 1.32
Combination therapy: a way to limit emergence of resistance? Am J Med (1986) 1.30
Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.24
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. II. Rhabdomyosarcomas. Am J Pathol (1988) 1.22
The effects of long-term rehabilitation therapy on poststroke hemiplegic patients. Stroke (1993) 1.19
Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae. Antimicrob Agents Chemother (1991) 1.16
Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate. J Antimicrob Chemother (1990) 1.13
Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha. Rheumatology (Oxford) (1999) 1.12
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice. J Antimicrob Chemother (1988) 1.12
Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Medicine (Baltimore) (1992) 1.11
Biochemistry and histology of the connective tissue of Dupuytren's disease lesions. Eur J Clin Invest (1980) 1.10
In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii. Antimicrob Agents Chemother (1989) 1.10
Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke (2001) 1.09
Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells. Antimicrob Agents Chemother (1991) 1.06
Effect of mucin on Campylobacter jejuni association and invasion on HEp-2 cells. Microb Pathog (1988) 1.05
Development of beta-lactam-resistant Enterobacter cloacae in mice. J Infect Dis (1987) 1.04
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii. Antimicrob Agents Chemother (1994) 1.02
Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat. Anesthesiology (1986) 1.01
Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study. Brain Res (1989) 1.00
Cortical regions contributing to the anterior commissure in man. Exp Brain Res (1999) 0.98
In vitro and in vivo effects of doxycycline on Toxoplasma gondii. Antimicrob Agents Chemother (1990) 0.98
C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob Agents Chemother (2001) 0.97
Activity of minocycline against Toxoplasma gondii infection in mice. J Antimicrob Chemother (1991) 0.96
Bacterial antibiotic efflux systems of medical importance. Cell Mol Life Sci (1999) 0.95
Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob Agents Chemother (1989) 0.95
Fish oil decreases natural resistance of mice to infection with Salmonella typhimurium. Metabolism (1992) 0.95
The effects of propofol anesthesia on local cerebral glucose utilization in the rat. Anesthesiology (1990) 0.94
Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother (1980) 0.94
Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells. J Leukoc Biol (2001) 0.94
Respective role of polymorphonuclear leukocytes and their integrins (CD-11/18) in the local or systemic toxicity of lipopolysaccharide. J Leukoc Biol (1993) 0.93
[Serum, lymph node and testicular concentrations of penicillin in 31 healthy or syphilitic rabbits treated with penicillin]. Pathol Biol (Paris) (1971) 0.93
Comparative study of the beta-lactamase activity found in Achromobacter. Can J Microbiol (1983) 0.91
Arteether, a qinghaosu derivative, in toxoplasmosis. Trans R Soc Trop Med Hyg (1988) 0.91
Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients. Antimicrob Agents Chemother (1976) 0.90
Macrophage oxidative metabolism and intracellular Toxoplasma gondii. Microb Pathog (1989) 0.90
Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg (1991) 0.90
Newly documented antimicrobial activity of quinolones. Eur J Clin Microbiol Infect Dis (1991) 0.89
Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J Antimicrob Chemother (1990) 0.89
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. J Antimicrob Chemother (1986) 0.87
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli. Infection (1994) 0.87
Usual and unusual antibacterial effects of quinolones. J Antimicrob Chemother (1990) 0.86
Dementia of the frontal type: neuropsychological and [99Tc]-HM-PAO SPET features. J Geriatr Psychiatry Neurol (1995) 0.86
Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel density. J Neurooncol (1999) 0.85
Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study. Drugs (1988) 0.85
Laboratory survey of fluoroquinolone activity. Rev Infect Dis (1989) 0.83
[Evolution of gentamicin sensitivity in acute postpartum staphylococcal endocarditis]. Ann Med Interne (Paris) (1972) 0.83
Well differentiated cerebellar tissue within a mature cystic teratoma. Pathol Res Pract (1998) 0.83
Efficacy of different dosing schedules of tobramycin for treating a murine Klebsiella pneumoniae bronchopneumonia. J Antimicrob Chemother (1987) 0.83
Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection. J Antimicrob Chemother (1988) 0.83
Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies. Brain Res (2000) 0.83
A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. J Neural Transm (Vienna) (2002) 0.83
Overexpression, refolding, and purification of the histidine-tagged outer membrane efflux protein OprM of Pseudomonas aeruginosa. Protein Expr Purif (2001) 0.82
Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary results. Acta Neurol Scand (1994) 0.82
Postantibiotic effect and host-bacteria interactions. J Antimicrob Chemother (1995) 0.82
Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics. J Neurochem (1984) 0.81
Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementia. Eur Neurol (1990) 0.81
Treatment of vascular graft infection by in situ replacement with cryopreserved aortic allografts: an experimental study. J Vasc Surg (1998) 0.81
Corticobasal degeneration: neuropsychological assessment and dopamine D2 receptor SPECT analysis. Eur Neurol (1995) 0.81
Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain. Brain Res (1985) 0.80
Salmonella typhimurium thyA mutants fail to grow intracellularly in vitro and are attenuated in mice. Microbiology (2001) 0.80
Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins. Infection (1978) 0.80
18F-FDG-PET/CT. Q J Nucl Med Mol Imaging (2012) 0.80
In-vitro toxoplasmacidal activity of cationic electron carriers. J Antimicrob Chemother (1989) 0.80
Effects of conventional and sensory-enhanced physiotherapy on disability of Parkinson's disease patients. Adv Neurol (1996) 0.80
Open study of ceftazidime in serious infections due to multiply-resistant bacteria. J Antimicrob Chemother (1983) 0.79
An unusual case of Creutzfeldt-Jakob disease. Neurology (1998) 0.79
Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J Hepatol (1998) 0.79
Beta-lactamases: clinical and genetic perspectives. J Antimicrob Chemother (1983) 0.79
Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis? Eur J Gastroenterol Hepatol (2004) 0.79
How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection? J Antimicrob Chemother (1989) 0.79
Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. Eur Neurol (1989) 0.79
Activity of roxithromycin against Toxoplasma gondii in murine models. J Antimicrob Chemother (1987) 0.78
Permeability and penicillin-binding protein alterations in Salmonella muenchen: stepwise resistance acquired during beta-lactam therapy. Antimicrob Agents Chemother (1989) 0.78
Malignant transformation of a spinal cord ganglioglioma--case report and review of the literature. Clin Neuropathol (2004) 0.78
Combined analysis of CSF betaA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data. J Neural Transm (Vienna) (2002) 0.78
Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann Vasc Surg (2001) 0.78
Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis. J Antimicrob Chemother (1994) 0.78
Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutants. J Antimicrob Chemother (1992) 0.78